Secoiridoid glycosides from the fruits of Ligustrum lucidum and their in vitro anti-inflammatory activity

Fitoterapia. 2023 Dec:171:105705. doi: 10.1016/j.fitote.2023.105705. Epub 2023 Oct 16.

Abstract

Seven new secoiridoid glycosides (1-7), together with a known analogue (8), were isolated from the fruits of Ligustrum lucidum. Their structures with absolute configurations were determined by HR-ESI-MS, 1D and 2D NMR, and electronic circular dichroism (ECD) spectroscopic analysis, as well as biogenetic consideration. Compounds 1 and 2 are the first examples of secoiridoid glycoside dimers featuring a rare rearranged oleoside-type secoiridoid moiety, and compounds 3-7 represent a new class of oleoside-type secoiridoid glycosides with unusual stereochemistry at C-1 position. A plausible biosynthetic pathway for this group of unusual secoiridoid glycosides was also proposed herein. In addition, the isolates were evaluated for their in vitro anti-inflammatory activity, and all tested compounds exhibited modest inhibitory effects against nitric oxide (NO) production in lipopolysaccharide (LPS)-induced RAW264.7 macrophages.

Keywords: Anti-inflammatory activity; Ligustrum lucidum; Secoiridoid glycoside.

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Fruit / chemistry
  • Glycosides / analysis
  • Glycosides / pharmacology
  • Iridoid Glycosides* / chemistry
  • Iridoid Glycosides* / pharmacology
  • Ligustrum* / chemistry
  • Molecular Structure

Substances

  • Iridoid Glycosides
  • Anti-Inflammatory Agents
  • Glycosides